SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bal Pharma appoints additional Director

28 Mar 2015 Evaluate

Bal Pharma has informed that the Board of Directors of the Company at its meeting held on March 27, 2015 has appointed Sarika Bhandari as additional Director on the Board of the Company.

The above information is a part of company’s filings submitted to BSE

Bal Pharma Share Price

77.19 0.00 (0.00%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1660.20
Dr. Reddys Lab 1209.85
Cipla 1224.00
Zydus Lifesciences 924.65
Lupin 2288.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×